Florida Dem Who Suffered a Meltdown When New Maps Were Passed Has Been...
Former Mumford and Sons Member Was Not Happy With What This Guest Said...
You'll Never Guess What the Anti-Gunners are Trying to Ban Now
Gavin Newsom Is Lying About California's 'Balanced' Budget
After Failing to Pass a Radical Gun Control Bill, a Minnesota Democrat Responded...
Yale Faculty Report Admits Higher Ed Trust Crisis Self-Inflicted
Driver Rams Pedestrians in Modena, Italy; Eight Injured in Suspected Terror Attack
U.S. Secret Service Seized 14 Skimmers, Stopped $14.5M of Fraud in Houston Area
McMorrow Pushed Water Affordability While Racking Up $3,000 Unpaid Utility Tab at Million-...
USDA SNAP Data Integrity Team Finds About $3B of Fraud Across 20+ States
The Virginia Democrat Behind the Illegal Theft of Republican Seats Launches Fundraiser for...
THE BOYS: A Love Letter to People Who Hate You
Maryland Woman Gets 3.5 Years for $3.5 Million COVID Unemployment Fraud Scheme
Anti-Police Remarks From This Arizona Democrat Resurface During National Police Week
Is This Anti-Trump Republican Now Hiding His Payments to His Democrat Consultant?
Tipsheet

Rapid Response Test Was Just Approved for the Wuhan Coronavirus

Rapid Response Test Was Just Approved for the Wuhan Coronavirus
AP Photo/Ted S. Warren

The United States Food and Drug Administration (FDA) on Friday announced that the agency approved the first of its kind rapid response test to detect the Wuhan coronavirus. The agency used an emergency use authorization to fast-track the test's approval. According to the FDA, the test's results are produced roughly 45 minutes after the test is administered. 

Advertisement

The company producing the tests, Cepheid, said the test was designed so that the tests could be used in the 5,000 GeneXpert testing systems throughout the country. This means hospitals could receive results at the point-of-care. These systems are automated, do not require specific training and are capable of running 24/7, something hospitals across the nation already do.

"During this time of increased demand for hospital services, Clinicians urgently need an on-demand diagnostic test for real-time management of patients being evaluated for admission to health-care facilities," Dr. David Persing, MD, Ph.D., Chief Medical and Technology Officer at Cepheid said in a statement. "An accurate test delivered close to the patient can be transformative — and help alleviate the pressure that the emergence of the 2019-nCoV outbreak has put on healthcare facilities that need to properly allocate their respiratory isolation resources."

Cepid said the tests will begin shipping next week.

Although these test will be readily available, Dr. Anthony Fauci, the Director of the National Institute of Allergy and Infectious Diseases, said asymptomatic people should not be tested for the Wuhan coronavirus. Doing so puts health care workers at greater risk because of the lack of personal protective equipment [PPE].

Advertisement

Related:

CORONAVIRUS FDA

"Let me tell you about one of the unintended consequences of individuals who don't need to get tested flood the desire to get tested. Currently, and I hope we will be able to change it, and make it much less reliable, PPEs," he explained during Saturday's press conference. "When you go in and get tested, you are consuming personal protective equipment: masks and gowns. Those are high priority for the health care workers who are taking care of people who have coronavirus disease."

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement